• Home
  • News
  • Events
  • ISNS Info
    • ISNS Facts
    • ISNS Regions
    • Guthrie award
    • Dussault medal
    • Loeber award
    • Constitution
    • Guidelines
    • How to become a member
  • Links
  • Membership-info
  • Contact
  • Member login
  • English
    • Home
    • News
    • Events
    • ISNS Info
      • ISNS Facts
      • ISNS Regions
      • Guthrie award
      • Dussault medal
      • Loeber award
      • Constitution
      • Guidelines
      • How to become a member
    • Links
    • Membership-info
    • Contact
    • Member login
    • English

    Glutaryl-CoA dehydrogenase deficiency : a study showed that newborn screening programs for Glutaric aciduria type 1 have an overall positive effect on the neurological outcome but their success depends on the quality of therapy

    • Consult the pubmed abstract
    • To read more about “Glutaryl-CoA dehydrogenase deficiency”
    • Genet Med . 2021 Jan;23(1):13-21.

    (source: OrphaNews 10 May 2021)

    Related news

    Appropriate consent and health rights of children: Understanding the ethics of genomic newborn screening

    A new article has been published in the European Journal of Human Gene...

    Understanding the role of patient organisations in promoting and developing newborn screening

    A new article has been published in Rare Disease and Orphan Drugs Jour...

    The WHO/World Health Assembly adopts resolution concerning maternal, newborn and child mortality

    The WHO/World Health Assembly adopts resolution A77/A/CONF./5 “A...

    Dominican Republic moves to implement neonatal screening

    Please see this link: https://dominicantoday.com/dr/health/2024/04/09/...

    Methods for estimating rare disease prevalence

    A new article has been published in Rare Disease and Orphan Drugs Jour...

    New European Commission fact sheet on rare diseases

    The European Commission has published a new fact sheet titled “EU Ac...

    Copyright 2020 ISNS - International Society for Neonatal Screening

    Development by Best4u Media B.V.